BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30040460)

  • 1. Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: Ten Years of Clinical Experience in Relation to International Guidelines.
    Hjerpe A; Abd-Own S; Dobra K
    Arch Pathol Lab Med; 2018 Aug; 142(8):893-901. PubMed ID: 30040460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
    Ascoli V; Minelli G; Cozzi I; Romeo E; Carnovale Scalzo C; Ancona L; Forastiere F
    Pathol Res Pract; 2016 Oct; 212(10):886-892. PubMed ID: 27485167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
    Hjerpe A; Ascoli V; Bedrossian CW; Boon ME; Creaney J; Davidson B; Dejmek A; Dobra K; Fassina A; Field A; Firat P; Kamei T; Kobayashi T; Michael CW; Önder S; Segal A; Vielh P; ;
    Diagn Cytopathol; 2015 Jul; 43(7):563-76. PubMed ID: 26100969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology.
    Hjerpe A; Ascoli V; Bedrossian CWM; Boon ME; Creaney J; Davidson B; Dejmek A; Dobra K; Fassina A; Field A; Firat P; Kamei T; Kobayashi T; Michael CW; Önder S; Segal A; Vielh P
    Acta Cytol; 2015; 59(1):2-16. PubMed ID: 25824655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
    McGregor SM; Dunning R; Hyjek E; Vigneswaran W; Husain AN; Krausz T
    Hum Pathol; 2015 Nov; 46(11):1670-8. PubMed ID: 26376834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary statement from the international mesothelioma interest group, also endorsed by the international academy of cytology and the papanicolaou society of cytopathology. A proposal to be applauded and promoted but which requires updating.
    Sheaff M
    Diagn Cytopathol; 2020 Oct; 48(10):877-879. PubMed ID: 31976625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers and prognostic factors for malignant pleural mesothelioma.
    Vigneri P; Martorana F; Manzella L; Stella S
    Future Oncol; 2015; 11(24 Suppl):29-33. PubMed ID: 26638920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Cytology in the Current Guidelines for Malignant Mesothelioma: Largest Study from India.
    Kaur K; Patel T; Samanta S; Patra S; Trivedi P
    Acta Cytol; 2021; 65(2):175-185. PubMed ID: 33316798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis.
    Abd Own S; Höijer J; Hillerdahl G; Dobra K; Hjerpe A
    Diagn Cytopathol; 2021 May; 49(5):606-614. PubMed ID: 32049443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in malignant pleural mesothelioma.
    Davidson B
    Hum Pathol; 2015 Jun; 46(6):789-804. PubMed ID: 25824607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on the recently published "Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma".
    Hjerpe A; Dobra K
    Cancer Cytopathol; 2015 Aug; 123(8):449-53. PubMed ID: 26097077
    [No Abstract]   [Full Text] [Related]  

  • 12. What's new in mesothelioma.
    Ascoli V; Murer B; Nottegar A; Luchini C; Carella R; Calabrese F; Lunardi F; Cozzi I; Righi L
    Pathologica; 2018 Mar; 110(1):12-28. PubMed ID: 30259910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the cytological criteria in the diagnosis of malignant pleural mesothelioma: Making the bridge between theory and practice.
    Mlika M; Yaiche R; Ayadi R; Braham E; Abdennadher M; Mezni F
    Tunis Med; 2023 May; 101(5):497-501. PubMed ID: 38372516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma.
    Sherman ME; Mark EJ
    Arch Pathol Lab Med; 1990 Aug; 114(8):845-51. PubMed ID: 2375659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
    Le Stang N; Burke L; Blaizot G; Gibbs AR; Lebailly P; Clin B; Girard N; Galateau-Sallé F;
    Arch Pathol Lab Med; 2020 Apr; 144(4):446-456. PubMed ID: 31389715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pleural mesothelioma: an update on diagnosis and treatment options.
    Kondola S; Manners D; Nowak AK
    Ther Adv Respir Dis; 2016 Jun; 10(3):275-88. PubMed ID: 26873306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnosis of malignant mesothelioma in effusion cytology: a reappraisal and results of a multi-institution survey.
    Paintal A; Raparia K; Zakowski MF; Nayar R
    Cancer Cytopathol; 2013 Dec; 121(12):703-7. PubMed ID: 24039177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value.
    Shaker N; Wu D; Abid AM
    Diagn Cytopathol; 2022 Nov; 50(11):532-537. PubMed ID: 36069384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
    Chapel DB; Churg A; Santoni-Rugiu E; Tsujimura T; Hiroshima K; Husain AN
    Lung Cancer; 2019 Jan; 127():69-75. PubMed ID: 30642555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
    Husain AN; Colby T; Ordonez N; Krausz T; Attanoos R; Beasley MB; Borczuk AC; Butnor K; Cagle PT; Chirieac LR; Churg A; Dacic S; Fraire A; Galateau-Salle F; Gibbs A; Gown A; Hammar S; Litzky L; Marchevsky AM; Nicholson AG; Roggli V; Travis WD; Wick M;
    Arch Pathol Lab Med; 2013 May; 137(5):647-67. PubMed ID: 22929121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.